GA Depot (Long-acting IM Injection of Glatiramer Acetate) Presents Improved Safety and Tolerability Features: Results from a Multinational, Double-blind, Placebo-controlled Phase III Study in Subjects with Relapsing Forms of Multiple Sclerosis (P8-6.018)

Compare GA Depot's safety and tolerability to Copaxone's® published data on injection site reactions (ISRs), serious adverse events (SAEs) and immediate post injection reactions (IPIRs).